Rice Hall James & Associates LLC Sells 342 Shares of Xylem Inc. (NYSE:XYL)

Rice Hall James & Associates LLC trimmed its holdings in Xylem Inc. (NYSE:XYL) by 3.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,073 shares of the industrial products company’s stock after selling 342 shares during the quarter. Rice Hall James & Associates LLC’s holdings in Xylem were worth $1,366,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. EverSource Wealth Advisors LLC raised its stake in Xylem by 68.8% during the 1st quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock valued at $25,000 after purchasing an additional 77 shares during the last quarter. Blue Trust Inc. increased its holdings in shares of Xylem by 1,185.7% during the 2nd quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock worth $35,000 after purchasing an additional 249 shares during the period. FinTrust Capital Advisors LLC raised its position in shares of Xylem by 170.9% during the first quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock valued at $41,000 after buying an additional 200 shares during the last quarter. Hazlett Burt & Watson Inc. lifted its stake in shares of Xylem by 184.9% in the first quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock valued at $43,000 after buying an additional 220 shares during the period. Finally, UMB Bank n.a. grew its position in Xylem by 96.9% during the second quarter. UMB Bank n.a. now owns 382 shares of the industrial products company’s stock worth $52,000 after buying an additional 188 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Stock Performance

NYSE:XYL opened at $129.87 on Thursday. The stock has a market capitalization of $31.49 billion, a P/E ratio of 46.22, a price-to-earnings-growth ratio of 2.23 and a beta of 1.04. The company has a current ratio of 1.85, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19. Xylem Inc. has a 1 year low of $87.59 and a 1 year high of $146.08. The firm has a 50 day moving average of $133.99 and a 200-day moving average of $133.87.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.04. The firm had revenue of $2.17 billion during the quarter, compared to the consensus estimate of $2.14 billion. Xylem had a return on equity of 9.48% and a net margin of 9.11%. The business’s revenue for the quarter was up 26.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.98 EPS. As a group, sell-side analysts anticipate that Xylem Inc. will post 4.26 EPS for the current fiscal year.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 26th. Stockholders of record on Thursday, August 29th will be paid a dividend of $0.36 per share. The ex-dividend date is Thursday, August 29th. This represents a $1.44 annualized dividend and a dividend yield of 1.11%. Xylem’s dividend payout ratio (DPR) is currently 51.25%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on XYL. Royal Bank of Canada raised their price objective on Xylem from $160.00 to $163.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 31st. Argus lifted their price target on shares of Xylem from $146.00 to $165.00 and gave the stock a “buy” rating in a research note on Wednesday, May 29th. Stifel Nicolaus increased their price objective on shares of Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research note on Wednesday, July 31st. TD Cowen reiterated a “hold” rating and set a $138.00 target price on shares of Xylem in a research report on Tuesday, September 3rd. Finally, UBS Group initiated coverage on shares of Xylem in a research report on Tuesday, August 13th. They issued a “buy” rating and a $165.00 price target for the company. Five research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat, Xylem presently has a consensus rating of “Moderate Buy” and a consensus target price of $147.54.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.